Bill
SF 1144
SF 1144 seeks to modify optometrists' authority to prescribe and administer drugs, reshaping prescribing scope for eye care and affecting patients, providers, and regulators.
SF 1144 — Optometrists limitations on prescribing and administering drugs provisions modifications
Overview
- Bill number/title: SF 1144, Optometrists limitations on prescribing and administering drugs provisions modifications
- Purpose (as stated): To modify the limitations on optometrists’ authority to prescribe and administer drugs.
- Status: Referred to Health and Human Services
- Introduced: February 10, 2025
- Companion: HF 1011 (House companion)
What the bill would do
- The bill is described as modifying the existing limitations on optometrists’ ability to prescribe and administer medications. The available information does not include the specific text of the provisions, so the exact changes (whether expansion, narrowing, or clarification of prescribing and drug-administration privileges) are not detailed here.
- Because the provisions are not provided in the summary, key topics commonly involved in this area (for example, which drugs may be prescribed or administered, required training or supervision, practice settings, dispensing responsibilities, recordkeeping, and patient safety safeguards) cannot be confirmed from the provided material.
Who would be affected
- Optometrists: potentially impacted in terms of their scope of practice, prescribing authority, and methods of drug administration.
- Patients receiving eye care: any changes to optometric prescribing and drug administration could affect access to medications used in eye care.
- Health care system and regulators: depending on the final language, regulatory oversight, supervision requirements, and professional standards could be adjusted.
- Related health professionals and pharmacies: changes in prescribing authority may influence collaboration with other clinicians and medication dispensing processes.
Procedural and timeline aspects
- Introduction and first reading occurred on February 10, 2025.
- The bill was referred to the Health and Human Services committee on the same day.
- The House companion HF 1011 may provide parallel language and assist in tracking potential floor action and amendments.
- Current timeline beyond referral depends on committee action, potential amendments, and subsequent floor votes in the Senate; no further actions are listed in the provided material.
Notes for readers and stakeholders
- The essential specifics of the proposed modifications are not included in the material provided. For a precise understanding, review the full text of SF 1144 and any amendments, as well as related hearing materials and the companion HF 1011.
- Monitor committee hearings in Health and Human Services and any updates to HF 1011 for potential changes, dates, and sponsors.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
